Company Overview of Cognosci Inc.
Cognosci Inc. engages in discovering and developing anti-inflammatory compounds for the treatment of neuroinflammatory diseases. Its products include COG112 to treat multiple sclerosis; and COG1410 to treat traumatic brain injuries and Alzheimer’s disease. The company also offers products to treat ischemic stroke/subarachnoid hemorrhage, spinal cord injury, Parkinson's disease, rheumatoid arthritis, and sepsis. Cognosci was founded in 2000 and is based in Research Triangle Park, North Carolina.
79 T. W. Alexander Drive
4401 Research Commons
Research Triangle Park, NC 27709
Founded in 2000
Key Executives for Cognosci Inc.
Similar Private Companies By Industry
|DPT Laboratories, Ltd.||United States|
|Centella Therapeutics, Inc.||United States|
|CG Nutritionals, Inc.||United States|
|Pharmasol Corporation||United States|
|DrugAbuse Sciences, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Cognosci Inc., please visit www.cognosci.com. Company data is provided by Capital IQ. Please use this form to report any data issues.